Form 4: ICU Medical Executive Daniel Woolson Reports Stock Transactions
SEC Form 4
Daniel Woolson, VP, GM-Infusion Capital at ICU Medical, reports the vesting and disposal of restricted stock units.
Summary
- Daniel Woolson, a VP, GM-Infusion Capital at ICU Medical Inc., reported transactions involving common stock on March 7th and 8th, 2025.
- These transactions involved the vesting of restricted stock units (RSUs) and the subsequent disposal of shares to cover tax obligations.
- On March 7th, 966 shares vested and were converted to common stock, and 467 shares were disposed of at a price of $141.97.
- On March 8th, 2,153 shares vested and were converted to common stock, and 953 shares were disposed of at a price of $141.97.
- Following these transactions, Woolson directly owns 12,565 shares of ICU Medical Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions, with no inherent positive or negative sentiment.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation.
Key Dates
| Date | Description |
|---|---|
| 03/07/2023 | Grant date anniversary for restricted stock units. |
| 03/07/2025 | Vesting and disposal of shares reported. |
| 03/08/2025 | Vesting and disposal of shares reported. |
| 03/10/2025 | Date of form submission. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.